普济消毒饮联合利巴韦林对流行性腮腺炎患者的影响

Effect of General Antiphlogistic Decoction Combined with Ribavirin on Patients with Mumps

目的分析讨论普济消毒饮联合利巴韦林对流行性腮腺炎患者的影响。方法整体选取2013年5月—2015年10月期间该院接收腮腺炎患者,共计117例,根据自主意愿选择治疗方式,58例患者选择利巴韦林治疗,为对照组,另外59例患者选择普济消毒饮联合利巴韦林治疗,为观察组,比较两组患者治疗后效果及不良反应。结果经过系统治疗后,上述患者症状基本得到缓解,对照组、观察组患者临床效率分别为72.41%、98.31%,差异具有统计学意义(P<0.05);两组患者治疗后不良反应发生率分别为3.45%、6.78%,观察组患者略高于对照组,但差异无统计学意义(P>0.05)。结论对于流行性腮腺炎患者,临床应用普济消毒饮联合利巴韦林进行治疗,临床效果更明显,且用药安全性较高,建议推广。

Objective To analyze and discuss the effect of general antiphlogistic decoction combined with ribavirin on patients with mumps. Methods 117 cases of patients with mumps treated in our hospital from May 2013 to October 2015 were divided into two groups, the treatment methods were selected by patients according to their willingness, the control group（n=58） were treated with ribavirin, the observation group（n=59） were treated with general antiphlogistic decoction combined with ribavirin, the effect and adverse reactions after treatment of the two groups were compared. Results After systemic treatment, the above symptoms of patients had been alleviated basically, the clinical effective rate was 72.41% in the control group and 98.31% in the observation group, and the difference was statistically significant（P〈0.05）, the incidence of adverse reactions after treatment in the observation group was slightly higher than that in the control group,（6.78% vs3.45%）, but the difference had not statistical significance,（P〈 0.05）. Conclusion The application of general antiphlogistic decoction combined with ribavirin in treatment of patients with mumps in clinic has a more obvious clinical effect and higher medication safety, which is suggested to be promoted.